Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: A case series study

Koh Hei Sonoda, H. Enaida, A. Ueno, T. Nakamura, Y. I. Kawano, T. Kubota, T. Sakamoto, T. Ishibashi

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Aim: To examine the outcome of a triamcinolone acetonide (TA) assisted pars plana vitrectomy (PPV) for refractory uveitis. Methods: Six patients suffering from proliferative vitreoretinopathy (PVR) with refractory uveitis underwent a TA assisted PPV. The patients consisted of one with Vogt-Koyanagi-Harada disease, one with acute retinal necrosis, one with Behçet's disease, and three with sarcoidosis. TA was inoculated into the vitreous cavity to visualise the vitreous. In four of six patients, 4 mg of TA were intentionally left in the vitreous cavity to reduce the degree of postoperative inflammation. Results: The vitreous body was clearly seen using TA during surgery, which greatly helped us to perform a posterior hyaloid resection safely and thoroughly. As we previously observed in other disease, TA allowed us to visualise the transparent vitreous and thus was helpful in removing the vitreous cortex from the retina completely in uveitis. One patient (Behçet's disease, in whom TA was intentionally left) showed an elevated intraocular pressure (IOP) transiently after surgery which was controllable by topical eye drops. The remaining TA diminished day by day and had almost completely disappeared within a month from operation. Conclusion: TA improved the visibility of the hyaloid and the safety of the surgical procedures and no serious complications were observed after TA assisted PPV in uveitis. Although the long term effects are still unknown, this method appears to be potentially useful as an improved treatment for PVR associated with refractory uveitis.

Original languageEnglish
Pages (from-to)1010-1014
Number of pages5
JournalBritish Journal of Ophthalmology
Volume87
Issue number8
DOIs
Publication statusPublished - Aug 1 2003

Fingerprint

Triamcinolone Acetonide
Temazepam
Vitrectomy
Uveitis
Proliferative Vitreoretinopathy
Acute Retinal Necrosis Syndrome
Uveomeningoencephalitic Syndrome
Vitreous Body
Ophthalmic Solutions
Sarcoidosis
Intraocular Pressure
Retina
Inflammation
Safety

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis : A case series study. / Sonoda, Koh Hei; Enaida, H.; Ueno, A.; Nakamura, T.; Kawano, Y. I.; Kubota, T.; Sakamoto, T.; Ishibashi, T.

In: British Journal of Ophthalmology, Vol. 87, No. 8, 01.08.2003, p. 1010-1014.

Research output: Contribution to journalArticle

Sonoda, Koh Hei ; Enaida, H. ; Ueno, A. ; Nakamura, T. ; Kawano, Y. I. ; Kubota, T. ; Sakamoto, T. ; Ishibashi, T. / Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis : A case series study. In: British Journal of Ophthalmology. 2003 ; Vol. 87, No. 8. pp. 1010-1014.
@article{2a78507e0ca9481d9de2a587063caad6,
title = "Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: A case series study",
abstract = "Aim: To examine the outcome of a triamcinolone acetonide (TA) assisted pars plana vitrectomy (PPV) for refractory uveitis. Methods: Six patients suffering from proliferative vitreoretinopathy (PVR) with refractory uveitis underwent a TA assisted PPV. The patients consisted of one with Vogt-Koyanagi-Harada disease, one with acute retinal necrosis, one with Beh{\cc}et's disease, and three with sarcoidosis. TA was inoculated into the vitreous cavity to visualise the vitreous. In four of six patients, 4 mg of TA were intentionally left in the vitreous cavity to reduce the degree of postoperative inflammation. Results: The vitreous body was clearly seen using TA during surgery, which greatly helped us to perform a posterior hyaloid resection safely and thoroughly. As we previously observed in other disease, TA allowed us to visualise the transparent vitreous and thus was helpful in removing the vitreous cortex from the retina completely in uveitis. One patient (Beh{\cc}et's disease, in whom TA was intentionally left) showed an elevated intraocular pressure (IOP) transiently after surgery which was controllable by topical eye drops. The remaining TA diminished day by day and had almost completely disappeared within a month from operation. Conclusion: TA improved the visibility of the hyaloid and the safety of the surgical procedures and no serious complications were observed after TA assisted PPV in uveitis. Although the long term effects are still unknown, this method appears to be potentially useful as an improved treatment for PVR associated with refractory uveitis.",
author = "Sonoda, {Koh Hei} and H. Enaida and A. Ueno and T. Nakamura and Kawano, {Y. I.} and T. Kubota and T. Sakamoto and T. Ishibashi",
year = "2003",
month = "8",
day = "1",
doi = "10.1136/bjo.87.8.1010",
language = "English",
volume = "87",
pages = "1010--1014",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis

T2 - A case series study

AU - Sonoda, Koh Hei

AU - Enaida, H.

AU - Ueno, A.

AU - Nakamura, T.

AU - Kawano, Y. I.

AU - Kubota, T.

AU - Sakamoto, T.

AU - Ishibashi, T.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Aim: To examine the outcome of a triamcinolone acetonide (TA) assisted pars plana vitrectomy (PPV) for refractory uveitis. Methods: Six patients suffering from proliferative vitreoretinopathy (PVR) with refractory uveitis underwent a TA assisted PPV. The patients consisted of one with Vogt-Koyanagi-Harada disease, one with acute retinal necrosis, one with Behçet's disease, and three with sarcoidosis. TA was inoculated into the vitreous cavity to visualise the vitreous. In four of six patients, 4 mg of TA were intentionally left in the vitreous cavity to reduce the degree of postoperative inflammation. Results: The vitreous body was clearly seen using TA during surgery, which greatly helped us to perform a posterior hyaloid resection safely and thoroughly. As we previously observed in other disease, TA allowed us to visualise the transparent vitreous and thus was helpful in removing the vitreous cortex from the retina completely in uveitis. One patient (Behçet's disease, in whom TA was intentionally left) showed an elevated intraocular pressure (IOP) transiently after surgery which was controllable by topical eye drops. The remaining TA diminished day by day and had almost completely disappeared within a month from operation. Conclusion: TA improved the visibility of the hyaloid and the safety of the surgical procedures and no serious complications were observed after TA assisted PPV in uveitis. Although the long term effects are still unknown, this method appears to be potentially useful as an improved treatment for PVR associated with refractory uveitis.

AB - Aim: To examine the outcome of a triamcinolone acetonide (TA) assisted pars plana vitrectomy (PPV) for refractory uveitis. Methods: Six patients suffering from proliferative vitreoretinopathy (PVR) with refractory uveitis underwent a TA assisted PPV. The patients consisted of one with Vogt-Koyanagi-Harada disease, one with acute retinal necrosis, one with Behçet's disease, and three with sarcoidosis. TA was inoculated into the vitreous cavity to visualise the vitreous. In four of six patients, 4 mg of TA were intentionally left in the vitreous cavity to reduce the degree of postoperative inflammation. Results: The vitreous body was clearly seen using TA during surgery, which greatly helped us to perform a posterior hyaloid resection safely and thoroughly. As we previously observed in other disease, TA allowed us to visualise the transparent vitreous and thus was helpful in removing the vitreous cortex from the retina completely in uveitis. One patient (Behçet's disease, in whom TA was intentionally left) showed an elevated intraocular pressure (IOP) transiently after surgery which was controllable by topical eye drops. The remaining TA diminished day by day and had almost completely disappeared within a month from operation. Conclusion: TA improved the visibility of the hyaloid and the safety of the surgical procedures and no serious complications were observed after TA assisted PPV in uveitis. Although the long term effects are still unknown, this method appears to be potentially useful as an improved treatment for PVR associated with refractory uveitis.

UR - http://www.scopus.com/inward/record.url?scp=0041704992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041704992&partnerID=8YFLogxK

U2 - 10.1136/bjo.87.8.1010

DO - 10.1136/bjo.87.8.1010

M3 - Article

C2 - 12881346

AN - SCOPUS:0041704992

VL - 87

SP - 1010

EP - 1014

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 8

ER -